State Street Corp Sonoma Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 24,315 shares of SNOA stock, worth $78,051. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,315
Previous 24,315
-0.0%
Holding current value
$78,051
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SNOA
# of Institutions
19Shares Held
435KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il195KShares$626,4530.0% of portfolio
-
Geode Capital Management, LLC Boston, MA86.6KShares$278,1270.0% of portfolio
-
Jane Street Group, LLC New York, NY45.3KShares$145,3960.0% of portfolio
-
Hrt Financial LP New York, NY21.5KShares$69,0750.0% of portfolio
-
Xtx Topco LTD London, X019.8KShares$63,6670.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $9.95M
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...